Tag: Steepest
Between 2025 and 2030, the pharmaceutical industry faces its most dramatic patent cliff in history, with up to $300 billion in branded drug revenues exposed to generic competition. The upheaval…
Between 2025 and 2030, the pharmaceutical industry faces its most dramatic patent cliff in history, with up to $300 billion in branded drug revenues exposed to generic competition. The upheaval…